Clinical Trial Update: Stereotactic Body Radiation Therapy in Treating Patients With Recurrent Primary Ovarian or Uterine Cancer [Phase 1]

View source ↗

Summary

This clinical trial update reports on a Phase 1 study of stereotactic body radiation therapy for recurrent primary ovarian or uterine cancers, including endomet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer
• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Snippet

Sponsor: University of Colorado, Denver | Conditions: Recurrent Endometrial Serous Adenocarcinoma, Recurrent Fallopian Tube Carcinoma | Phase 1 | Status: COMPLETED